<SEC-DOCUMENT>0001178913-26-001750.txt : 20260326
<SEC-HEADER>0001178913-26-001750.hdr.sgml : 20260326
<ACCEPTANCE-DATETIME>20260326084116
ACCESSION NUMBER:		0001178913-26-001750
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260318
FILED AS OF DATE:		20260326
DATE AS OF CHANGE:		20260326

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mark Elad
		CENTRAL INDEX KEY:			0001960205
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37353
		FILM NUMBER:		26794490

	MAIL ADDRESS:	
		STREET 1:		27 HAILANOT
		CITY:			HERZLIYA
		STATE:			L3
		ZIP:			4631214

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scinai Immunotherapeutics Ltd.
		CENTRAL INDEX KEY:			0001611747
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000
		BUSINESS PHONE:		972-8-9302529

	MAIL ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BiondVax Pharmaceuticals Ltd.
		DATE OF NAME CHANGE:	20140624
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>zk2634962.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0607</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2026-03-18</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001611747</issuerCik>
        <issuerName>Scinai Immunotherapeutics Ltd.</issuerName>
        <issuerTradingSymbol>SCNI</issuerTradingSymbol>
        <issuerForeignTradingSymbol></issuerForeignTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001960205</rptOwnerCik>
            <rptOwnerName>Mark Elad</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerNonUSAddressFlag>true</rptOwnerNonUSAddressFlag>
            <rptOwnerStreet1>C/O SCINAI IMMUNOTHERAPEUTICS LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>JERUSALEM BIOPARK, 2ND FLOOR</rptOwnerStreet2>
            <rptOwnerCity>JERUSALEM</rptOwnerCity>
            <rptOwnerNonUSStateTerritory></rptOwnerNonUSStateTerritory>
            <rptOwnerCountry>L3</rptOwnerCountry>
            <rptOwnerZipCode>9112002</rptOwnerZipCode>
            <rptOwnerStateDescription>ISRAEL</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Operating Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Ordinary shares, no par value per share (&quot;Ordinary Shares&quot;)</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>160355016</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>American Depositary Shares</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F4"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>13460984</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The Ordinary Shares are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.</footnote>
        <footnote id="F2">Includes 20,355,016 Ordinary Shares that are represented by restricted share units (&quot;RSUs&quot;) that were granted on January 25, 2024, of which 25% vested on the six-month anniversary thereof, 8.33% vested on the 12-month anniversary thereof, and 66.66% vest in two equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Each RSU represents a contingent right to receive one Ordinary Share upon vesting.</footnote>
        <footnote id="F3">Includes 140,000,000 Ordinary Shares that are represented by RSUs that were granted on November 12, 2025, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.</footnote>
        <footnote id="F4">Represents approximately 3,365 American Depositary Share, which is convertible at any time into 13,460,984 Ordinary Shares, at the holder's election and has no expiration date.</footnote>
    </footnotes>

    <remarks>Exhibit 24 - Power of Attorney.</remarks>

    <ownerSignature>
        <signatureName>/s/ Amir Reichman, Attorney-in-Fact</signatureName>
        <signatureDate>2026-03-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>exhibit_24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: zk-global
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 24</font></u><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;"> <br>
      </font></div>
    <br>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">LIMITED POWER OF ATTORNEY<br>
      </font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Know all by these present, that the undersigned hereby constitutes and appoints each of Amir Reichman and Uri Ben-Or (each, an &#8220;<font style="font-weight: bold; font-style: italic;">Attorney-in-fact</font>&#8221;),

      or any of them acting singly and with full power of substitution, as the undersigned&#8217;s true and lawful attorney-in-fact to:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -14.2pt; margin-left: 49.65pt; line-height: 1.25;">1.&#160; prepare, submit, execute for, and on behalf of the undersigned, in the undersigned&#8217;s capacity as an officer or director, as applicable, of Scinai
      Immunotherapeutics Ltd. (the &#8220;Company&#8221;), (a) Forms 3, 4, and 5 (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder and (b) any other forms or reports
      the undersigned may be required to file in connection with the undersigned&#8217;s ownership, acquisition, or disposition of securities of the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on the Electronic Data Gathering, Analysis, and
      Retrieval system (&#8220;EDGAR&#8221;) of the SEC;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -14.2pt; margin-left: 49.65pt; line-height: 1.25;">2.&#160; do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or
      5, or other form or report (or any amendment thereto), and timely file such schedule, form or report with the SEC on EDGAR and any stock exchange or similar authority;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -14.2pt; margin-left: 49.65pt; line-height: 1.25;">3.&#160; seek or obtain, as the undersigned&#8217;s representative and on the undersigned&#8217;s behalf, information on transactions in the Company&#8217;s securities from any
      broker or financial institution, and the undersigned hereby authorizes any such person to release any such information to each of the Attorneys- in-fact and approves and ratifies any such release of information; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: -14.2pt; margin-left: 49.65pt; line-height: 1.25;">4.&#160; take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such Attorney-in-fact, may be of benefit to, in
      the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such Attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms
      and conditions as such Attorney-in-fact may approve in such Attorney-in-fact&#8217;s discretion.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned acknowledges that this Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such
      Attorney-in-Fact without independent verification of such information, and any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such
      information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned hereby grants to each such Attorney-in-Fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be
      done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all
      that such Attorneys-in-Fact, or such Attorney-in-Fact's designated substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the
      foregoing Attorneys-in-Fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is Scinai Immunotherapeutics Ltd. assuming, any of the undersigned&#8217;s responsibilities to comply with Section 16 of the Securities
      Exchange Act of 1934, and this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned&#8217;s obligations under Section 13 or Section 16 of the Exchange Act, including, without limitation, the reporting
      requirements under Section 13 or Section 16 of the Exchange Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This Power of Attorney, with respect to each of the Attorneys-in-Fact, shall remain in full force and effect until the earlier of (a) the date that the undersigned is no longer
      required to file Forms 3, 4, and 5 with respect to the undersigned&#8217;s beneficial ownership and transactions in securities issued by the Company, (b) this Power of Attorney is revoked by the undersigned in a signed writing delivered to such
      Attorneys-in-Fact, or (c) the time at which such Attorney-in-Facts are no longer employed by Scinai Immunotherapeutics Ltd.</div>
    <br>
    <div style="text-indent: 36pt; line-height: 1.25;">IN WITNESS WHEREOF, the undersigned has executed this Limited Power of Attorney as of this 26<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of March, 2026.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table id="z9de1689417254fcba7a9cbbd5b6c2e4c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">SIGNED AND ACKNOWLEDGED</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By: <u>/s/ Elad Mark</u></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Name: Elad Mark</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <br>
    <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
